| 000 | 00819 a2200205 4500 | ||
|---|---|---|---|
| 005 | 20250517201738.0 | ||
| 008 | ####s 0 0 eng d | ||
| 022 | _a2163-0402 | ||
| 024 | 7 |
_a10.1212/CPJ.0b013e31825a77ca _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSatya-Murti, Saty | |
| 245 | 0 | 0 |
_aAn analysis of AAN's evidence-based guideline for IVIg use in neurologic disorders: Provider impact and payer perspectives. _h[electronic resource] |
| 260 |
_bNeurology. Clinical practice _cJun 2012 |
||
| 300 |
_a134-138 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 700 | 1 | _aShepard, Katie M | |
| 700 | 1 | _aKaufman, Joel M | |
| 773 | 0 |
_tNeurology. Clinical practice _gvol. 2 _gno. 2 _gp. 134-138 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/CPJ.0b013e31825a77ca _zAvailable from publisher's website |
| 999 |
_c28085677 _d28085677 |
||